Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF A Multicenter Study

Journal of the American College of Cardiology

Volumn 66, Issue 23, 2015, Pages 2579-2589

  Netuka, Ivan ^a,b   Sood, Poornima ^c   Pya, Yuriy ^d   Zimpfer, Daniel ^e   Krabatsch, Thomas ^f   Garbade, Jens ^g   Rao, Vivek ^h   Morshuis, Michiel ⁱ   Marasco, Silvana ^j   Beyersdorf, Friedhelm ^k   Damme, Laura ^c   Schmitto, Jan D ^l  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Clinical Affairs   (United States)

^d National Research Cardiac Surgery Center   (Kazakhstan)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h TORONTO GENERAL HOSPITAL   (Canada)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j ALFRED HOSPITAL   (Australia)

^k UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

HeartMate 3; hemolysis; pump; quality of life; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; HEPARIN; INOTROPIC AGENT; WARFARIN; CARDIOTONIC AGENT;

ADULT; ARTICLE; BLEEDING; CENTRIFUGAL PUMP; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE SAFETY; DRIVELINE INFECTION; DRUG DOSE TITRATION; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL HEMORRHAGE; GENERAL DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MAGNETICALLY LEVITATED ROTOR; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REOPERATION; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; AGED; CLINICAL TRIAL; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HEART STROKE VOLUME; HEART VENTRICLE; HEMODYNAMICS; LONG TERM CARE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; CARDIOTONIC AGENTS; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84949851555     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.083     Document Type: Article

References (38)

1. R.C. Starling, Y. Naka, A.J. Boyle, and et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous-flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
2. R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy Ann Thorac Surg 86 2008 1227 1234 discussion 1234-5
3. R. John, Y. Naka, N.G. Smedira, and et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial Ann Thorac Surg 92 2011 1406 1413 discussion 1413
4. J. Cowger, K. Sundareswaran, J.G. Rogers, and et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score J Am Coll Cardiol 61 2013 313 321
5. J.M. Schaffer, J.G. Allen, E.S. Weiss, and et al. Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
6. S. Crow, R. John, A. Boyle, and et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
7. J.A. Morgan, G. Paone, H.W. Nemeh, and et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device J Heart Lung Transplant 31 2012 715 718
8. L. Harvey, C.T. Holley, and R. John Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention Ann Cardiothorac Surg 3 2014 475 479
9. M.R. Mehra, G.C. Stewart, and P.A. Uber The vexing problem of thrombosis in long-term mechanical circulatory support J Heart Lung Transplant 33 2014 1 11
10. N. Yuan, G.J. Arnaoutakis, T.J. George, and et al. The spectrum of complications following left ventricular assist device placement J Card Surg 27 2012 630 638
11. K. Takeda, Y. Naka, J.A. Yang, and et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion J Heart Lung Transplant 33 2014 141 148
12. J.J. Nienaber, S. Kusne, T. Riaz, and et al. Clinical manifestations and management of left ventricular assist device-associated infections Clin Infect Dis 57 2013 1438 1448
13. S. Crow, D. Chen, C. Milano, and et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients Ann Thorac Surg 90 2010 1263 1269 discussion 1269
14. M. Baghai, C. Heilmann, F. Beyersdorf, and et al. Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices Eur J Cardiothorac Surg 48 2015 421 427
15. T. Hasin, S. Deo, J.J. Maleszewski, and et al. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD ASAIO J 60 2014 9 14
16. M.S. Slaughter, M.A. Sobieski 2nd, J.D. Graham, P.S. Pappas, A.J. Tatooles, and S.C. Koenig Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device Int J Artif Organs 34 2011 461 468
17. A.L. Meyer, D. Malehsa, C. Bara, and et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circ Heart Fail 3 2010 675 681
18. J.D. Schmitto, J.S. Hanke, S.V. Rojas, M. Avsar, and A. Haverich First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III) J Heart Lung Transplant 34 2015 858 860
19. E.S. Ketchum, A.J. Moorman, D.P. Fishbein, and et al. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement J Heart Lung Transplant 29 2010 1021 1025
20. Interagency Registry for Mechanically Assisted Circulatory Support. Appendix A - Adverse Event Definitions. Available at: https://www.uab.edu/medicine/intermacs/protocol-3-archive/appendices/appendix-a. Accessed September 1, 2015.
21. J. Lahpor, A. Khaghani, R. Hetzer, and et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients Eur J Cardiothorac Surg 37 2010 357 361
22. F.D. Pagani, L.W. Miller, S.D. Russell, and et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
23. M.S. Slaughter, J.G. Rogers, C.A. Milano, and et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
24. D. Esmore, D. Kaye, P. Spratt, and et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy J Heart Lung Transplant 27 2008 579 588
25. N. Moazami, R.J. Steffen, Y. Naka, and et al. Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial Ann Thorac Surg 98 2014 541 547
26. M. Morshuis, A. El-Banayosy, L. Arusoglu, and et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system Eur J Cardiothorac Surg 35 2009 1020 1027 discussion 1027-8
27. A.F. Popov, M.T. Hosseini, B. Zych, and et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure Ann Thorac Surg 93 2012 810 815
28. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
29. M. Strueber, R. Larbalestier, P. Jansz, and et al. Results of the post-market Registry to Evaluate the HeartWare left Ventricular Assist System (ReVOLVE) J Heart Lung Transplant 33 2014 486 491
30. M. Strueber, G. O'Driscoll, P. Jansz, and et al. Multicenter evaluation of an intrapericardial left ventricular assist system J Am Coll Cardiol 57 2011 1375 1382
31. T.M. de By, P. Mohacsi, J. Gummert, and et al. The European Registry for Patients with mechanical Circulatory Support (EUROMACS): first annual report Eur J Cardiothorac Surg 47 2015 770 777
32. A.J. Boyle, U.P. Jorde, B. Sun, and et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients J Am Coll Cardiol 63 2014 880 888
33. M.C. Bunte, E.H. Blackstone, L. Thuita, and et al. Major bleeding during HeartMate II support J Am Coll Cardiol 62 2013 2188 2196
34. K.D. Aaronson, M.S. Slaughter, L.W. Miller, and et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
35. A.M. Dell'Aquila, S.R. Schneider, D. Schlarb, and et al. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report Ann Thorac Surg 95 2013 170 177
36. D. Dean, F. Kallel, G.A. Ewald, and et al. Reduction in driveline infection rates: results from the HeartMate II multicenter Driveline Silicone Skin Interface (SSI) Registry J Heart Lung Transplant 34 2015 781 789
37. U.P. Jorde, N. Uriel, N. Nahumi, and et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients Circ Heart Fail 7 2014 310 319
38. S.W. Pak, N. Uriel, H. Takayama, and et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices J Heart Lung Transplant 29 2010 1172 1176